BMEYE, a spin out of TNO, is a technology-based, market driven company which was established in April 2005. Leveraging a highly validated method based on decades of fundamental technology and sensor research within TNO, BMEYE provides researchers, clinicians and patients worldwide with safe, precise and easy-to-use solutions for continuous, entirely non-invasive, cardiovascular monitoring.
The Nexfin, BMEYE’s first product launch, obtained CE and FDA clearance in 2007, is a unique non invasive blood pressure and cardiac output monitor using a comfortable finger sensor, offering a precise, full hemodynamic profile with real-time data posted within a minute.

Speaker Profile

Rob de Ree, MSc - Chief Executive Officer

Rob de Ree, MSc - Chief Executive Officer - has over 15 years experience
in the healthcare industry in sales, marketing and business management.
Rob worked for 8 years for Medtronic in multiple national and
international roles including the responsibility to build the European
venture business for the Octopus and other minimally invasive cardiac
surgery products and as the European Marketing Director responsible for
product marketing and market development for the ICD, pacing and electro
physiology business for Medtronic. Rob joined BMEYE in June 2007 as the
VP Sales & Marketing and was appointed to CEO in January 2008.